$ESPR: Esperion Announces Late-Breaking Oral Presentation of Final Study …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Esperion (NASDAQ:ESPR), today announced that the final Phase 3 results from Study 3 (1002-046, also known as CLEAR …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675551/esperion-announces-late-breaking-oral-presentation-of-final-study-3-re

Related News:

$ESPR: Bempedoic Acid Study 1 Results Published in The New England …

$ESPR: Esperion Therapeutics, Inc. (NASDAQ:ESPR): Is It A Good Long …

$ESPR: Esperion Announces Inducement Grants Under NASDAQ Listing …

$RCUS $EGO $ESPR: Why Arcus Biosciences, Eldorado Gold, and Esperion Therapeutics …

$ESPR: Esperion inks deal with Daiichi Sankyo Europe to commercialize …

$ESPR $OR: Is Esperion Therapeutics, Inc. (ESPR) A Good Stock To Buy?

$ALG $ESPR $KANG: Hedge Funds Aren’t Showing Much Interest in Alamo Group, Inc. (ALG)

$PXD $ESPR $PCTY: Report: Exploring Fundamental Drivers Behind American Vanguard …

$ESPR: Esperion Announces Positive Top-Line Results from Final Pivotal …

$ESPR: Esperion Announces Completion of Phase 3 LDL-C Lowering …

$ESPR: Esperion up 8% premarket

Latest News:

$ABBV $CELG $DVA: 3 Bargain Stocks You Can Buy Today

$ACB $CGC $TLRY: Don’t Laugh: Aurora Cannabis, Canopy Growth, and Tilray Could Be …

$FIVE: Five Below Earnings: What to Watch

$ALB $SQM: Albemarle vs. SQM vs. Livent: Which Had the Best Lithium Results in …

$PEGI $BEP: Is Pattern Energy Group a Buy?

$AAPL: All the New Hardware Apple Released Last Week

$TSLA: Registration data suggests slump in Tesla sales

$T $VIA: AT&T Pushes Xandr Ad Products in Viacom Carriage Talks

$VIX: From Lyft to Airbnb, new round of IPOs is no market top: Nick Colas

$ASND: Ascendis Pharma Announces Phase 3 heiGHt Trial Demonstrated …

$MKC: McCormick Earnings: What to Watch